Taro Pharmaceutical Industries Ltd (TARO)

90.89 +0.48  +0.53% NYSE Nov 21, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/22/2020 08:00 EDT Misc Taro Pharmaceutical Industries Ltd Fourth Quarter Earnings Conference Call in 2020
02/06/2020 Earnings Taro Pharmaceutical Industries Ltd Third Quarter Earnings Results in 2020
11/05/2019 08:00 EST Misc Taro Pharmaceutical Industries Ltd Second Quarter Earnings Conference Call in 2020
11/04/2019 Earnings Taro Pharmaceutical Industries Ltd Second Quarter Earnings in 2020 Release
08/08/2019 Earnings Taro Pharmaceutical Industries Ltd First Quarter Earnings Results in 2020
06/20/2019 Misc Taro Pharmaceutical Industries Ltd Annual Report in 2019
05/23/2019 08:00 EDT Misc Taro Pharmaceutical Industries Ltd Fourth Quarter Earnings Conference Call in 2019
05/22/2019 Earnings Taro Pharmaceutical Industries Ltd Fourth Quarter Earnings in 2019 Release
02/06/2019 Earnings Taro Pharmaceutical Industries Ltd Third Quarter Earnings Results in 2019
12/10/2018 Dividends Amount: 12.81, Declared Date: Nov 05 2018, Pay Date: Dec 28 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.taro.com
  • Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=114698&p=irol-irhome
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Feb. 06, 2020
  • Last Earnings Release: Nov. 04, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Dec. 10, 2018
  • Description: Taro Pharmaceutical Industries Ltd produces, researches, develops and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Top Fund Holders

Symbol Name Weighting
PJP Invesco Dynamic Pharmaceuticals ETF 2.89%
AMDCX AMIDEX35 Israel C 2.30%
JPLS JPMorgan Long/Short ETF 0.40%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.